Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ciprofol vs propofol on short- and medium-term renal function in kidney transplant recipients
ChiCTR2200064881Phase 4Not yet recruiting
- Sponsor
- Guangxi Medical University Second Affiliated Hospital
- Start
- Oct 2022
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in end-stage kidney disease (ESKD) comparing Propofol group with Ciprofol group (2 arms). Primary endpoints: Blood urea nitrogen, Serum creatinine and 3 more. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
ciprofolpropofol
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on ChiCTR2200064881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200064881.